Protocol for Deformulation of Pharmaceutical Products

Step 1: Literature Analysis

This step involves gathering publicly available information about the RLD's formulation. Sources include the FDA's "Drugs@FDA" database, prescribing information, and patent literature. These sources help identify potential excipients and provide initial insights into the formulation strategy.

Step 2: Physicochemical Characterization

Key physicochemical properties of the RLD are determined, including melting point, hygroscopicity, pH solubility profile, stability against hydrolysis and oxidation, etc. These analyses guide subsequent extraction and quantification steps.

Step 3: Decoding the Quantitative Formula

Identifying and quantifying excipients is crucial for replicating functionality and achieving bioequivalence. Key excipients may include:

Extraction techniques include selective solubility, filtration, and chromatographic separation. Quantification is performed via gravimetry, HPLC, HPTLC, or size exclusion chromatography, depending on the analyte type and concentration.

Step 4: Solid-State Characterization of the API

Characterizing the API's solid form is critical due to its impact on dissolution, stability, and bioavailability. Evaluated parameters include:

Techniques used include powder X-Ray diffraction (PXRD), differential scanning calorimetry (DSC), FTIR, NIR, and Raman spectroscopy

Step 5: Identification of the Manufacturing Process

Understanding the manufacturing method is essential for process replication. Factors such as API sensitivity, excipient compatibility, and tablet integrity provide clues to the production technique (e.g., direct compression, wet/dry granulation). Tablet fracture morphology, particle size distribution, and blending uniformity are analyzed using SEM, image analysis, and content uniformity assays.

Deformulation is an indispensable tool in modern pharmaceutical development, enabling the creation of bioequivalent generics, improving formulation understanding, and enhancing regulatory readiness. As a leading materials analysis and testing company, Alfa Chemistry provides end-to-end deformulation services, supporting clients from initial RLD analysis to regulatory submission. Whether for tablets, capsules, or complex formulations, our expertise ensures accurate, efficient, and compliant development of generic pharmaceutical products.